Free Trial
NASDAQ:ENGNW

enGene (ENGNW) Stock Price, News & Analysis

enGene logo
$0.76 -0.09 (-10.79%)
As of 02/21/2025 03:11 PM Eastern

About enGene Stock (NASDAQ:ENGNW)

Key Stats

Today's Range
$0.75
$0.90
50-Day Range
$0.75
$1.13
52-Week Range
$0.42
$6.50
Volume
48,591 shs
Average Volume
9,207 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

Receive ENGNW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for enGene and its competitors with MarketBeat's FREE daily newsletter.

ENGNW Stock News Headlines

Elon Social Security shock?
“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One Boston based think tank believes it could have drastic impacts on your money and life in America.
See More Headlines

ENGNW Stock Analysis - Frequently Asked Questions

enGene's stock was trading at $0.8433 at the start of the year. Since then, ENGNW shares have decreased by 9.5% and is now trading at $0.7630.
View the best growth stocks for 2025 here
.

Shares of ENGNW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ENGNW
Fax
N/A
Employees
31
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
N/A
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:ENGNW) was last updated on 2/23/2025 by MarketBeat.com Staff
From Our Partners